Nikko Asset Management Americas’s Standard BioTools LAB Stock Holding History

Nikko Asset Management Americas’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$338K	Sell	412,288 -30,496	-7%	-$28.8K	﹤0.01%	185
2026 Q1	$407K	Sell	442,784 -3,893,103	-90%	-$4.71M	0.01%	182
2025 Q4	$5.51M	Sell	4,335,887 -1,055,942	-20%	-$1.42M	0.06%	104
2025 Q3	$7.01M	Sell	5,391,829 -764,273	-12%	-$1M	0.07%	99
2025 Q2	$7.33M	Sell	6,156,102 -77,591	-1%	-$86K	0.07%	94
2025 Q1	$6.73M	Sell	6,233,693 -384,701	-6%	-$540K	0.09%	92
2024 Q4	$11.5M	Sell	6,618,394 -2,954,098	-31%	-$5.5M	0.12%	83
2024 Q3	$18.4M	Sell	9,572,492 -1,069,779	-10%	-$2.09M	0.21%	71
2024 Q2	$18.7M	Buy	10,642,271 +1,788,780	+20%	+$4.37M	0.22%	69
2024 Q1	$24M	Buy	+8,853,491	New	+$21.4M	0.24%	64

Other funds holding LAB

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Nikko Asset Management Americas's LAB Position: Q2 2026 in Review

Nikko Asset Management Americas reduced its Standard BioTools (LAB) stake by 6.9% in Q2 2026, selling an estimated $28.8K and leaving 412,288 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #185.

Nikko Asset Management Americas first reported a position in LAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $24M in Q1 2024. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Nikko Asset Management Americas held 412,288 shares of Standard BioTools worth $338K as of Q2 2026.
Nikko Asset Management Americas sold 30,496 Standard BioTools shares in Q2 2026, an estimated $28.8K.
Standard BioTools made up ﹤0.01% of Nikko Asset Management Americas's portfolio in Q2 2026, its #185 holding.
Nikko Asset Management Americas first reported a position in Standard BioTools in Q1 2024 and has held it in 10 quarters since.
Nikko Asset Management Americas's Standard BioTools position peaked at $24M in Q1 2024.
144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.